Ny användning av azatricykloderivat och farmaceutiska kompositioner innehållande desamma

摘要

The compounds of formula I, have been found to have excellent topical activity. They are thus indicated for use in the topical treatment of inflammatory and hyperpoliferative skin diseases and of cutaneous manifestations of immunologically-induced illnesses, such as psoriasis.